254
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Methylglyoxal induced advanced glycation end products (AGE)/receptor for AGE (RAGE)-mediated angiogenic impairment in bone marrow-derived endothelial progenitor cells

, , , , &

References

  • Ackah, E., J. Yu, S. Zoellner, Y. Iwakiri, C. Skurk, R. Shibata, N. Ouchi, R. M. Easton, G. Galasso, M. J. Birnbaum, K. Walsh, and W. C. Sessa. 2005. Akt1/protein kinase B alpha is critical for ischemic and VEGF-mediated angiogenesis. The Journal of Clinical Investigation 115:2119–27. doi:10.1172/JCI24726.
  • Alev, C., M. Ii, and T. Asahara. 2011. Endothelial progenitor cells: A novel tool for the therapy of ischemic diseases. Antioxidants Redox Signalling 15:949–65. doi:10.1089/ars.2010.3872.
  • Antonio, N., R. Fernandes, A. Soares, F. Soares, A. Lopes, T. Carvalheiro, A. Paiva, G. M. Pego, L. A. Providencia, L. Goncalves, and C. F. Ribeiro. 2014. Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: Accompanying the glycemic continuum. Cardiovascular Diabetologica 13:101. doi:10.1186/1475-2840-13-101.
  • Asahara, T., H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver, M. Kearne, M. Magner, and J. M. Isner. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research 85:221–28. doi:10.1161/01.RES.85.3.221.
  • Bodiga, V. L., S. R. Eda, and S. Bodiga. 2014. Advanced glycation end products: Role in pathology of diabetic cardiomyopathy. Heart Failure Reviews 19:49–63. doi:10.1007/s10741-013-9374-y.
  • Brouwers, O., P. M. Niessen, G. Haenen, T. Miyata, M. Brownlee, C. D. Stehouwer, J. G. De Mey, and C. G. Schalkwijk. 2010. Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia 53:989–1000. doi:10.1007/s00125-010-1677-0.
  • Caliceti, C., P. Nigro, P. Rizzo, and R. Ferrari. 2014. ROS, Notch, and Wnt signaling pathways: Crosstalk between three major regulators of cardiovascular biology. Biomedical Researcher International 2014:1–8. doi:10.1155/2014/318714.
  • Chamorro-Jorganes, A., E. Araldi, L. O. Penalva, D. Sandhu, C. Fernandez-Hernando, and Y. Suarez. 2011. MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arteriosclerosis, Thrombosis, and Vascular Biology 31:2595–606. doi:10.1161/ATVBAHA.111.236521.
  • Che, W., M. Asahi, M. Takahashi, H. Kaneto, A. Okado, S. Higashiyama, and N. Taniguchi. 1997. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. The Journal of Biological Chemistry 272:18453–59.
  • Chen, J., J. Jing, S. Yu, M. Song, H. Tan, B. Cui, and L. Huang. 2016. Advanced glycation endproducts induce apoptosis of endothelial progenitor cells by activating receptor RAGE and NADPH oxidase/JNK signaling axis. American Journal Transl Researcher 8:2169–78.
  • Chen, J., M. Song, S. Yu, P. Gao, Y. Yu, H. Wang, and L. Huang. 2010. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overexpression of cell oxidant stress. Molecular and Cellular Biochemistry 335:137–46. doi:10.1007/s11010-009-0250-y.
  • Chen, Q., L. Dong, L. Wang, L. Kang, and B. Xu. 2009. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Biochemical and Biophysical Research Communications 381:192–97. doi:10.1016/j.bbrc.2009.02.040.
  • Cook, L. J., J. Davies, A. P. Yates, A. C. Elliott, J. Lovell, J. A. Joule, P. Pemberton, P. J. Thornalley, and L. Best. 1998. Effects of methylglyoxal on rat pancreatic beta-cells. Biochemical Pharmacology 55:1361–67. doi:10.1016/S0006-2952(97)00619-9.
  • Cooper, M. E. 2004. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. American Journal Hypertens 17:S31–S38. doi:10.1016/j.amjhyper.2004.08.021.
  • Deane, R., I. Singh, A. P. Sagare, R. D. Bell, N. T. Ross, B. LaRue, R. Love, S. Perry, N. Paquette, R. J. Deane, M. Thiyagarajan, T. Zarcone, G. Fritz, A. E. Friedman, B. L. Miller, and B. V. Zlokovic. 2012. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. The Journal of Clinical Investigation 122:1377–92. doi:10.1172/JCI58642.
  • Dimmeler, S., E. Dernbach, and A. M. Zeiher. 2000. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Letters 477:258–62. doi:10.1016/S0014-5793(00)01657-4.
  • Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Natural Reviews Cancer 2:161–74. doi:10.1038/nrc745.
  • Fleming, T., J. Cuny, G. Nawroth, Z. Djuric, P. M. Humpert, M. Zeier, A. Bierhaus, and P. P. Nawroth. 2012. Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates? Diabetologia 55:1151–55. doi:10.1007/s00125-012-2452-1.
  • Fulton, D., J. P. Gratton, T. J. McCabe, J. Fontana, Y. Fujio, K. Walsh, T. F. Franke, A. Papapetropoulos, and W. C. Sessa. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597–601. doi:10.1038/21218.
  • Georgescu, A., N. Alexandru, A. Constantinescu, I. Titorencu, and D. Popov. 2011. The promise of EPC-based therapies on vascular dysfunction in diabetes. European Journal of Pharmacology 669:1–6. doi:10.1016/j.ejphar.2011.07.035.
  • Goldin, A., J. A. Beckman, A. M. Schmidt, and M. A. Creager. 2006. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114:597–605. doi:10.1161/CIRCULATIONAHA.106.621854.
  • Guariguata, L., D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw. 2014. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Researcher Clinical Practical 103:137–49. doi:10.1016/j.diabres.2013.11.002.
  • Guo, Y., P. Xia, J. J. Zheng, X. B. Sun, X. D. Pan, X. Zhang, and C. Z. Wu. 2015. Receptors for advanced glycation end products (RAGE) is associated with microvessel density and is a prognostic biomarker for clear cell renal cell carcinoma. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 73:147–53. doi:10.1016/j.biopha.2015.06.006.
  • Han, Y., E. Randell, S. Vasdev, V. Gill, V. Gadag, L. A. Newhook, M. Grant, and D. Hagerty. 2007. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Molecular and Cellular Biochemistry 305:123–31. doi:10.1007/s11010-007-9535-1.
  • Hanssen, N. M., J. W. Beulens, S. van Dieren, J. L. Scheijen, A. D. van der, A. M. Spijkerman, Y. T. van der Schouw, C. D. Stehouwer, and C. G. Schalkwijk. 2015. Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: A case-cohort study with a median follow-up of 10 years (EPIC-NL). Diabetes 64:257–65. doi:10.2337/db13-1864.
  • Kalka, C., H. Masuda, T. Takahashi, W. M. Kalka-Moll, M. Silver, M. Kearney, T. Li, J. M. Isner, and T. Asahara. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proceedings National Academic Sciences U S A 97:3422–27. doi:10.1073/pnas.97.7.3422.
  • Kim, J. H., M. H. Cho, K. C. Choi, K. Lee, K. S. Kim, and S. M. Shim. 2015. Oxidative stress induced by cigarette smoke extracts in human brain cells (T98G) and human brain microvascular endothelial cells (HBMEC) in mono- and co-culture. Journal Toxicological Environment Health A 78:1019–27. doi:10.1080/15287394.2015.1043607.
  • Kim, K. A., Y. J. Shin, M. Akram, E. S. Kim, K. W. Choi, H. Suh, C. H. Lee, and O. N. Bae. 2014. High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment. Biological & Pharmaceutical Bulletin 37:1248–52. doi:10.1248/bpb.b14-00172.
  • Kim, K. A., Y. J. Shin, J. H. Kim, H. Lee, S. Y. Noh, S. H. Jang, and O. N. Bae. 2012. Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms. Archives of Pharmacal Research 35:223–34. doi:10.1007/s12272-012-0203-y.
  • Krajnak, K., G. R. Miller, and S. Waugh. 2018. Contact area affects frequency-dependent responses to vibration in the peripheral vascular and sensorineural systems. Journal Toxicological Environment Health A 81:6–19. doi:10.1080/15287394.2017.1401022.
  • Lapolla, A., R. Flamini, A. Dalla Vedova, A. Senesi, R. Reitano, D. Fedele, E. Basso, R. Seraglia, and P. Traldi. 2003. Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method. Clinical Chemistry and Laboratory Medicine : CCLM / FESCC 41:1166–73. doi:10.1515/CCLM.2003.180.
  • Lee, S. B., J. H. Kim, M. H. Cho, E. S. Choe, K. S. Kim, and S. M. Shim. 2017. Impact of commercial cigarette smoke condensate on brain tissue co-cultured with astrocytes and blood-brain barrier endothelial cells. Journal Toxicological Environment Health A 80:533–41. doi:10.1080/15287394.2017.1355863.
  • Libby, P., and R. T. Lee. 2000. Matrix matters. Circulation 102:1874–76. doi:10.1161/01.CIR.102.16.1874.
  • Liu, H., S. Yu, H. Zhang, and J. Xu. 2012. Angiogenesis impairment in diabetes: Role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2. PLoS One 7:e46720. doi:10.1371/journal.pone.0046720.
  • Loomans, C. J., E. J. De Koning, F. J. Staal, M. B. Rookmaaker, C. Verseyden, H. C. de Boer, M. C. Verhaar, B. Braam, T. J. Rabelink, and A. J. van Zonneveld. 2004. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195–99. doi:10.2337/diabetes.53.1.195.
  • Murasawa, S., and T. Asahara. 2005. Endothelial progenitor cells for vasculogenesis. Physiology 20:36–42. doi:10.1152/physiol.00033.2004.
  • Oguri, G., T. Nakajima, Y. Yamamoto, N. Takano, T. Tanaka, H. Kikuchi, T. Morita, F. Nakamura, T. Yamasoba, and I. Komuro. 2014. Effects of methylglyoxal on human cardiac fibroblast: Roles of transient receptor potential ankyrin 1 (TRPA1) channels. American Journal of Physiology. Heart and Circulatory Physiology 307:H1339–H1352. doi:10.1152/ajpheart.01021.2013.
  • Pan, L., X. Ye, J. Ding, and Y. Zhou. 2017. Antiproliferation effect of the uremic toxin para cresol on endothelial progenitor cells is related to its antioxidant activity. Molecular Medica Reports 15:2308–12. doi:10.3892/mmr.2017.6230.
  • Piperi, C., A. Goumenos, C. Adamopoulos, and A. G. Papavassiliou. 2015. AGE/RAGE signalling regulation by miRNAs: Associations with diabetic complications and therapeutic potential. The International Journal of Biochemistry & Cell Biology 60:197–201. doi:10.1016/j.biocel.2015.01.009.
  • Qiu, M., Z. Yang, X. H. Guo, Y. T. Song, M. An, G. J. Zhao, M. Song, X. M. Zhao, Y. S. Zhao, and Q. L. Liu. 2017. Trichosanthin attenuates vascular injury-induced neointimal hyperplasia following balloon catheter injury in rats. Journal Toxicological Environment Health A 80:1212–21. doi:10.1080/15287394.2017.1367140.
  • Shao, G., S. Zhang, J. Nie, J. Li, and J. Tong. 2017. Effects of melatonin on mechanisms involved in hypertension using human umbilical vein endothelial cells. Journal Toxicological Environment Health A 80:1342–48. doi:10.1080/15287394.2017.1384171.
  • Sliwinska-Mosson, M., and H. Milnerowicz. 2017. The impact of smoking on the development of diabetes and its complications. Diab Vascular Diseases Researcher 14:265–76. doi:10.1177/1479164117701876.
  • Smadja, D. M., I. Bieche, D. Helley, I. Laurendeau, G. Simonin, L. Muller, M. Aiach, and P. Gaussem. 2007. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). Journal of Cellular and Molecular Medicine 11:1149–61. doi:10.1111/j.1582-4934.2007.00090.x.
  • Sorrentino, S. A., F. H. Bahlmann, C. Besler, M. Muller, S. Schulz, N. Kirchhoff, C. Doerries, T. Horvath, A. Limbourg, F. Limbourg, D. Fliser, H. Haller, H. Drexler, and U. Landmesser. 2007. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: Restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116:163–73. doi:10.1161/CIRCULATIONAHA.106.684381.
  • Taylor, K. L., A. M. Henderson, and C. C. Hughes. 2002. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvascular Research 64:372–83. doi:10.1006/mvre.2002.2443.
  • Tepper, O. M., R. D. Galiano, J. M. Capla, C. Kalka, P. J. Gagne, G. R. Jacobowitz, J. P. Levine, and G. C. Gurtner. 2002. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781–86. doi:10.1161/01.CIR.0000039526.42991.93.
  • Thornalley, P. J. 1996. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification–A role in pathogenesis and antiproliferative chemotherapy. General Pharmacology 27:565–73. doi:10.1016/0306-3623(95)02054-3.
  • Thornalley, P. J., S. Battah, N. Ahmed, N. Karachalias, S. Agalou, R. Babaei-Jadidi, and A. Dawnay. 2003. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. The Biochemical Journal 375:581–92. doi:10.1042/bj20030763.
  • Thornalley, P. J., N. I. Hooper, P. E. Jennings, C. M. Florkowski, A. F. Jones, J. Lunec, and A. H. Barnett. 1989. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Research and Clinical Practice 7:115–20. doi:10.1016/0168-8227(89)90101-0.
  • Tousoulis, D., N. Papageorgiou, E. Androulakis, G. Siasos, G. Latsios, K. Tentolouris, and C. Stefanadis. 2013. Diabetes mellitus-associated vascular impairment: Novel circulating biomarkers and therapeutic approaches. Journal of the American College of Cardiology 62:667–76. doi:10.1016/j.jacc.2013.03.089.
  • Urbich, C., and S. Dimmeler. 2004. Endothelial progenitor cells: Characterization and role in vascular biology. Circulation Research 95:343–53. doi:10.1161/01.RES.0000137877.89448.78.
  • van Dieren, S., J. W. Beulens, Y. T. van der Schouw, D. E. Grobbee, and B. Neal. 2010. The global burden of diabetes and its complications: An emerging pandemic. European Journal Cardiovascular Prevention Rehabilitation 17 (Suppl 1):S3–S8. doi:10.1097/01.hjr.0000368191.86614.5a.
  • van Grevenynghe, J., P. Monteiro, D. Gilot, T. Fest, and O. Fardel. 2006. Human endothelial progenitors constitute targets for environmental atherogenic polycyclic aromatic hydrocarbons. Biochemical and Biophysical Research Communications 341:763–69. doi:10.1016/j.bbrc.2006.01.028.
  • Vanhoutte, P. M., H. Shimokawa, M. Feletou, and E. H. Tang. 2017. Endothelial dysfunction and vascular disease-A 30th anniversary update. Acta Physiological 219:22–96.
  • Vulesevic, B., B. McNeill, F. Giacco, K. Maeda, N. J. Blackburn, M. Brownlee, R. W. Milne, and E. J. Suuronen. 2016. Methylglyoxal-induced endothelial cell loss and inflammation contribute to the development of diabetic cardiomyopathy. Diabetes 65:1699–713. doi:10.2337/db15-0568.
  • Wang, H., Q. H. Meng, J. R. Gordon, H. Khandwala, and L. Wu. 2007. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clinical Biochemistry 40:1232–39. doi:10.1016/j.clinbiochem.2007.07.016.
  • Werner, N., S. Junk, U. Laufs, A. Link, K. Walenta, M. Bohm, and G. Nickenig. 2003. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circulation Research 93:17e–24. doi:10.1161/01.RES.0000083812.30141.74.
  • Wils, J., J. Favre, and J. Bellien. 2017. Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes. Pharmacology & Therapeutics 170:98–115. doi:10.1016/j.pharmthera.2016.10.014.
  • Wu, L., and B. H. Juurlink. 2002. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39:809–14. doi:10.1161/hy0302.105207.
  • Wu, V. C., G. H. Young, P. H. Huang, S. C. Lo, K. C. Wang, C. Y. Sun, C. J. Liang, T. M. Huang, J. H. Chen, F. C. Chang, Y. L. Chen, Y. S. Kuo, J. B. Chen, J. W. Chen, Y. M. Chen, W. J. Ko, and K. D. Wu; NSARF group. 2013. In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: Modulation by statin. Angiogenesis 16:609–24. doi:10.1007/s10456-013-9339-8.
  • Xue, J., R. Ray, D. Singer, D. Bohme, D. S. Burz, V. Rai, R. Hoffmann, and A. Shekhtman. 2014. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry 53:3327–35. doi:10.1021/bi500046t.
  • Yang, Y. N., Y. T. Huang, and C. Y. Yang. 2017. Effects of a national smoking ban on hospital admissions for cardiovascular diseases: A time-series analysis in Taiwan. Journal Toxicological Environment Health A 80:562–68. doi:10.1080/15287394.2017.1367085.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.